Use of growth hormone for heart disease
Today, up to 40% of patients with heart disease are deficient in growth hormone. I recently analyzed the results of a randomized study to study the effectiveness of growth hormone replacement therapy in patients with heart disease who initially had its deficiency. Out of 158 patients aged from 18 to 80 years, 56 patients were selected who received either a growth hormone preparation (first group) or optimal drug therapy (second group). The inclusion criteria were as follows:
- the presence of growth hormone deficiency, confirmed by an arginine test;
- circulatory insufficiency of II-IV functional class;
- the end-diastolic volume of more than 60 ml;
- clinical stability at the time of enrollment in the study.
The study did not include patients with malignant tumors, active stages endocarditis, myocarditis, hepatitis, as well as acute myocardial infarction. The observation period was four years old. All 17 patients randomized to the growth hormone group completed the study, while that number was 14 in the standard medication group.
Combination of exercise and growth hormone for heart disease
Moderate physical activity in some cases is really indicated for certain heart diseases. Moreover, in the overwhelming majority of such cases, the appointment of a cardiologist should be the reason for starting regular physical activity. These classes should take place based on a specialized cardio center with qualified specialists and the necessary sports and diagnostic equipment. Otherwise, in the presence of heart disease, the independent manifestation of excessive activity can lead to unpredictable consequences. The same applies to taking a course of growth hormone – this is done only under the close supervision of a doctor.
If you have heart disease, you should never do high-intensity workouts using various techniques to increase intensity. Of course, we are talking about such bodybuilding exercises as squats, deadlifts, and many others. All heavy exercises place increased demands on the heart muscle and the smoothness of its work. The slightest deviation in the proper functioning of heart contractions and blood flow can lead to serious complications and even death. Therefore, physical activity should be carried out under the constant supervision of physicians who can control the load allowed for a particular person, as well as suspend stressful physical activity in time, if there are grounds for this.
Often, people with heart problems are prescribed moderate physical activity, which is primarily understood as: walking at a slow and medium pace, swimming and gymnastics in the water, specific breathing, and gymnastic exercises. As a rule, lessons are conducted smoothly and calmly, under the full supervision of experienced instructors. My research has shown that taking growth hormone in combination with moderate exercise can over time partially or completely restore vital organs, increase overall performance, and significantly improve metabolism.
First aid for a heart attack
A heart attack is a serious pathological condition caused by an acutely arising lack of blood supply to the heart muscle with the subsequent development of the death of a portion of this muscle. For a heart attack, the most typical:
- localization of pain in the chest area, pain can be given to the left hand to the forearm;
- the nature of the pain: pressing, squeezing, burning, or breaking intense pain;
- accompanied by shortness of breath, weakness, severe sweating;
- the duration of the pain is more than 5 minutes.
As for the use of growth hormone, my personal research has led to the following conclusions:
- Growth hormone affects the growth of the heart muscle and its ability to contract.
- Growth hormone activates the production of insulin-like growth factor 1 (IGF-1) by cardiomyocytes and vascular endothelial cells.
- Both together and separately, growth hormone and IGF-1 can increase vascular tone and, consequently, increase the peripheral resistance of the bloodstream.
- With age, the concentration of growth hormone and IGF-1 decreases.
In a recent study of 289 hypopituitarism patients lasting about 60 months, a surprising result was obtained: the incidence of myocardial infarction in patients on growth hormone replacement therapy is lower than in the general population.